About Curiosis
Curiosis is a company based in South Korea founded in 2015. It operates as a B2B and D2C. Curiosis offers products and services including Celloger® Pro, Celloger® Stack, MSP™ 320, FACSCOPE® B, and Cellpuri®. Curiosis operates in a competitive market with competitors including Multiply Labs, ThermoGenesis, Shenzhen Shenyan Biotechnology, Cellular Origins and Cytera, among others.
- Headquarter South Korea
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Curiosis Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Curiosis
Curiosis is a publicly listed company on the KRX with ticker symbol 494120 in South Korea. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Curiosis
Curiosis offers a comprehensive portfolio of products and services, including Celloger® Pro, Celloger® Stack, MSP™ 320, FACSCOPE® B, and Cellpuri®.
System for real-time cell monitoring inside incubators
Platform for multi-layer cell observation and culture
High-resolution scanner for digital slide analysis
Tool for automated cell counting and analysis
System for automated cell separation processes
Funding Insights of Curiosis
Detailed funding history for Curiosis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curiosis
Investment portfolio details for Curiosis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Curiosis
Detailed financials for Curiosis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Curiosis Comparisons
Peer comparison for Curiosis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Curiosis
Curiosis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Multiply Labs, ThermoGenesis, Shenzhen Shenyan Biotechnology, Cellular Origins and Cytera, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision medicines are manufactured via robotic systems for cell therapies.
|
|
| Locked | Locked | Locked |
Automated technologies for cell-based therapeutics and bio-processing are developed.
|
|
| Locked | Locked | Locked |
Automated cell processing systems are developed for gene therapies.
|
|
| Locked | Locked | Locked |
Automates cell therapy manufacturing through partnerships and robotics integration.
|
|
| Locked | Locked | Locked |
Automated cell culture devices using T-flasks and incubators are developed.
|
|
| Locked | Locked | Locked |
Robotic solutions for life science research are developed.
|
Detailed competitors of Curiosis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curiosis
Complete news archive for Curiosis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curiosis
Curiosis was founded in 2015.
Curiosis is headquartered in South Korea.
Curiosis develops advanced technologies for cell imaging, cell counting, isolation, and digital pathology. They offer products like the Celloger series for real-time monitoring in incubators and MSP for high-resolution slide scanning. Based in Seoul, Republic of Korea, the company focuses on enhancing lab productivity through innovative solutions, serving researchers in biotechnology and healthcare sectors.
Curiosis's top competitors include Multiply Labs, Celltrio and ThermoGenesis.
Curiosis offers Celloger® Pro, Celloger® Stack, MSP™ 320, FACSCOPE® B, and Cellpuri®.
Yes, Curiosis is publicly traded on KRX under the ticker symbol 494120.
The ticker symbol of Curiosis is 494120 on KRX.